100 Participants Needed

Supportive Housing Program for Homelessness

Recruiting at 1 trial location
AS
Overseen ByAndrew S Boozary, MD MPP CCFP
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University Health Network, Toronto
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on housing and health service use, so it's likely you can continue your medications, but please confirm with the study team.

What data supports the effectiveness of the treatment Social Medicine Housing Initiative for homelessness?

Research shows that supportive housing programs, like the Social Medicine Housing Initiative, can improve health and social outcomes for homeless individuals by providing stable housing and coordinated care, which includes access to physical health and social support services.12345

Is supportive housing safe for participants?

Supportive housing programs, which provide housing and support services, are generally considered safe for participants. However, there are challenges such as high-risk behaviors (like overdose and self-injury) that need to be managed to ensure safety and housing stability.16789

How does the Social Medicine Housing Initiative treatment differ from other treatments for homelessness?

The Social Medicine Housing Initiative is unique because it combines subsidized housing with site-based social services, aiming to improve health and residential stability for homeless individuals. Unlike other treatments, it focuses on providing stable housing as a foundation for addressing health and social issues, which can lead to greater satisfaction with living situations and improved quality of life.410111213

What is the purpose of this trial?

The study design is a cohort study with a propensity score-matched control group and difference-in-difference analysis to evaluate intervention effectiveness. A hybrid type 1 effectiveness-implementation study framework is used that incorporates mixed methods to determine clinical effectiveness and explore implementation and participant well-being. Participants are selected based on their utilization of health services. Selection favoured those individuals with the most health service utilization. A control group will be created by selecting individuals from administrative hospital records that are propensity-score matched to the individuals in the treatment group (1:4 pair). The hybrid type 1 effectiveness-implementation study framework was used to guide the selection of study aims and outcomes to focus primarily on clinical effectiveness, while also exploring implementation-related factors. The primary objective of the study is to evaluate the impact of the Initiative on the number of emergency department visits and days spent in the hospital. The secondary objectives are to 2) evaluate the impact of the Initiative on program participants' health and well-being, 3) evaluate the implementation of the Initiative and assess program fidelity and barriers, and 4) to calculate the cost avoidance and cost-effectiveness of the Initiative.

Research Team

AB

Andrew Boozary, MD MPP CCFP

Principal Investigator

University Health Network, Toronto

Eligibility Criteria

This trial is for adults who are unhoused and have complex health needs, with frequent hospital visits—specifically, at least 2 inpatient admissions or 6 emergency department visits in the past 6 months. Priority is given to Indigenous people, those without housing recently, women, gender-diverse individuals, and people with disabilities.

Inclusion Criteria

The Housing Initiative is part of standard care and is not contingent on participating in any research activities. Patients that participate in the Housing Initiative will have the option to participate in the research study.
To qualify for housing through the initiative, patients must have had 2 or more inpatient admissions or 6 or more visits to the emergency department in the past 6 months. They must also either identify as Indigenous or be currently without housing, which is defined as having spent at least one night in a shelter or having received assistance from city-funded street outreach providers in the past 90 days. Historically marginalized groups, including people with disabilities, women, gender-diverse individuals, and Indigenous people, are given priority for housing. Eligible patients are prioritized for housing offers based on their use of the University Health Network emergency departments in the past year.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants are provided with housing and support services as part of the Social Medicine Housing Initiative

30 months
Ongoing support and monitoring

Follow-up

Participants are monitored for health outcomes and healthcare utilization

30 months
Regular surveys and interviews

Data Analysis

Analysis of health data and cost-effectiveness of the program

Concurrent with intervention

Treatment Details

Interventions

  • Social Medicine Housing Initiative
Trial Overview The Social Medicine Housing Initiative is being evaluated through a cohort study comparing participants receiving the intervention to a matched control group from hospital records. The focus is on reducing emergency department visits and hospital stays while assessing participant well-being and cost-effectiveness of the program.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: University Health Network Standard CareExperimental Treatment1 Intervention
The Social Medicine Housing Initiative is part of standard care and is not contingent on participating in any research activities. Patients who participate in the Housing Initiative will have the option to participate in the research study. The Social Medicine Housing Initiative provides a housing-first approach which offers housing to individuals without prerequisites (e.g., requiring cessation of substance use, adherence to treatment). Through the Initiative, patients will receive access to permanent supportive housing and support services based on the Social Medicine model. Participants will not only have access to housing but will also be provided with customized social and medical support within and beyond the University Health Network, tailored to their specific needs and preferences.
Group II: Propensity score matched cohortActive Control1 Intervention
The Institute of Clinical Evaluative Sciences of Canada database will provide health administrative data on the Housing Initiative individuals and similar individuals. Each individual in the treatment arm will be matched with four individuals (1:4 pair) in the control arm who are observationally similar. The propensity score-matched cohort method will control for demand-side characteristics that reflect the utilization of health care services, focusing on the use of emergency department visits and inpatient hospital days, nursing home use, and inpatient utilization for severe mental illness. To assess whether the propensity score model has adequately specified, the authors will examine whether the distribution of measured baseline covariates is similar between treated and untreated subjects with the same estimated propensity score.

Social Medicine Housing Initiative is already approved in United States for the following indications:

🇺🇸
Approved in United States as Social Medicine Housing Initiative for:
  • Complex health needs in unhoused adults

Find a Clinic Near You

Who Is Running the Clinical Trial?

University Health Network, Toronto

Lead Sponsor

Trials
1,555
Recruited
526,000+

Findings from Research

Patients in a permanent supportive housing (PSH) program reported positive experiences with care coordination for physical health and social support services, indicating that these programs can effectively address some healthcare needs for individuals experiencing homelessness.
However, gaps in mental health support and assistance with securing public benefits were identified, suggesting that while PSH programs are beneficial, there is still room for improvement in comprehensive care coordination.
Perceived care coordination among permanent supportive housing participants: Evidence from a managed care plan in the United States.Palimaru, AI., McBain, RK., McDonald, K., et al.[2022]
The Navigator Programme, a case management intervention for homeless patients, is being rigorously evaluated in a randomized controlled trial involving 640 adults to assess its effectiveness in improving posthospital outcomes, particularly follow-up care within 14 days of discharge.
The study aims to measure various outcomes, including postdischarge mortality, readmission rates, and quality of care transitions, over a 180-day period, highlighting the potential for structured support to enhance healthcare access for vulnerable populations.
Navigator programme for hospitalised adults experiencing homelessness: protocol for a pragmatic randomised controlled trial.Liu, M., Pridham, KF., Jenkinson, J., et al.[2022]
Intensive case management significantly reduced the number of days individuals spent homeless and decreased substance and alcohol use, indicating its effectiveness in improving housing stability and health outcomes for homeless populations.
Assertive community treatment was found to be cost-effective compared to standard case management and showed protective effects against rehospitalizations, highlighting the importance of intervention intensity and tailored support in achieving better outcomes.
The effectiveness of case management interventions for the homeless, vulnerably housed and persons with lived experience: A systematic review.Ponka, D., Agbata, E., Kendall, C., et al.[2023]

References

Perceived care coordination among permanent supportive housing participants: Evidence from a managed care plan in the United States. [2022]
Navigator programme for hospitalised adults experiencing homelessness: protocol for a pragmatic randomised controlled trial. [2022]
The effectiveness of case management interventions for the homeless, vulnerably housed and persons with lived experience: A systematic review. [2023]
A comprehensive review of prioritised interventions to improve the health and wellbeing of persons with lived experience of homelessness. [2023]
"Because somebody cared about me. That's how it changed things": homeless, chronically ill patients' perspectives on case management. [2022]
The POP (Permanent Supportive Housing Overdose Prevention) Study: protocol for a hybrid type 3 stepped-wedge cluster randomized controlled trial. [2023]
Identifying variability in permanent supportive housing: A comparative effectiveness approach to measuring health outcomes. [2022]
Managing high-risk behaviours and challenges to prevent housing loss in permanent supportive housing: a rapid review. [2023]
Factors Associated With Premature Exits From Supported Housing. [2022]
10.United Statespubmed.ncbi.nlm.nih.gov
Residential placement for veterans with addiction: American Society of Addiction Medicine criteria vs. a veterans homeless program. [2022]
11.United Statespubmed.ncbi.nlm.nih.gov
Placement of chronically homeless into different types of permanent supportive housing before and after a coordinated entry system: The influence of severe mental illness, substance use disorder, and dual diagnosis on housing configuration and intensity of services. [2022]
12.United Statespubmed.ncbi.nlm.nih.gov
Health status, quality of life, residential stability, substance use, and health care utilization among adults applying to a supportive housing program. [2022]
13.United Statespubmed.ncbi.nlm.nih.gov
Creating a Regional Model to Coordinate and Prioritize Access to Permanent Supportive Housing. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security